Financial
Aspen building momentum in Commercial Pharmaceuticals and Manufacturing strategy modified
Aspen Pharmacare Holdings has reported financial results for the year ended 30 June 2025, with
Filter By:
Aspen Pharmacare Holdings has reported financial results for the year ended 30 June 2025, with
The true heroes of our Mandela Day campaign are our employees who continue to volunteer
Johannesburg, South Africa – Aspen Pharmacare, a global specialty and branded pharmaceutical company was honoured at the 4th South African Investment Conference (“SAIC”) when it
Cape Town, South Africa – JSE Limited-listed Aspen Pharmacare (APN), a global multinational specialty pharmaceutical company, has been presented with the South African Government and
Pretoria – The Chevalier de l’Ordre national du Mérite (Knight of the French National Order of Merit) was bestowed upon Stephen Saad, Aspen’s Group Chief
Aspen’s Group Treasury Team was recently recognised when they were awarded the highly acclaimed Adam Smith 2020 Best In Class Treasury Solution In Africa Award.
The annual FTSE Russell Environmental, Social and Governance (ESG) Ratings have been published and Aspen has been included as a constituent member in the global
Cape Town – JSE Limited-listed Aspen Pharmacare (APN), South Africa’s largest pharmaceutical company, was presented with the Economic Diplomacy (Africa) Award by the South African
Stephen Saad’s acceptance speech for the Entrepreneur of the Year Award at AABLA.
Aspen Holdings
www.aspenpharma.com
Hotline (South Africa)
0800 122 912
Medical Careline (South Africa) 0800 118 088
Shauneen Beukes
Group Communications Consultant
+27 31 580 8600
+27 82 389 8900
sbeukes@aspenpharma.com
